Skip to content

DEWULF SUZANNE KINESITHERAPIE

Active Private limited companyfounded 2020active for 6 yearsBurgemeester Pyckestraat 50, 8500 KortrijkKBO/BCE: BE 0740.748.418

Lifetime

5 annual accounts with figures on one time axis
peak of €65,531 in 2024
€17,307▼ 73.6%
lowest -€8,222 in 2022
€8,054▼ 75.5%
peak of €105,131 in 2025
€105,131▲ 8.3%
€130,721▼ 11.9%
Board1 name since 2019
1 director
Documentsfilings and deeds
27-03-202634 days before the deadline
2025micro format
Gross margin from €65,531 to €17,307Result from €32,914 to €8,054Investments €15,982Cash from €57,947 to €36,033

Key points

from the 2025 annual accounts

Equity

€105,131 ▲ 8.3%

DEWULF SUZANNE KINESITHERAPIE has made a profit without a break since 2023.

Turnover

≈ €100,000 estimated

The micro format states no turnover.

Investments

€15,982 3.3 times depreciation
2021202220242025

Green is investment, beige is depreciation.

Filings

5 annual accounts 1 late
deadline20222024

The 2021 accounts came 32 days late. The other four were filed on time.

Position in the sector

€8,054

Lower net result than 84% of companies in human health. Sector median €59,553 · 21,334 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 5,053 companies had the same profile as DEWULF SUZANNE KINESITHERAPIE has now. Each dot stands for 13 companies, two years later.

93.9%
were still trading
3.8%
stopped another way
2.2%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 5,053 companies, not a prediction for DEWULF SUZANNE KINESITHERAPIE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 24-12-2019
  • 40 sharesdeed of 08-01-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0740748418
Registered office moved from Roeselare to Kortrijk The registered office moved from Leenstraat 21 te 8800 Roeselare to Burgemeester Pyckestraat 50 te 8500 Kortrijk · Board meeting of 22-08-2024 · Gazette deed
Registered office moved within Roeselare The registered office moved from Baliestraat 42 te 8800 Roeselare to Leenstraat 21 te 8800 Roeselare · Board meeting of 23-08-2022 · Gazette deed
Incorporation Founding capital of €2,000, 40 shares · Founded by · appointed as director · published on 08-01-2020 · Gazette deed
All 13 events

Comparable companies

same main activity, similar in size and age
Company
DEWULF SUZANNE KINESITHERAPIE Kortrijk €235,852 €17,307 44.6% -
ReMOOV Beveren-Kruibeke-Zwijndrecht €238,249 €17,747 39.6% -
KINEZI Asse €275,539 €19,241 -20.2% -
Gertjan Van Gijsegem Aalst €235,855 €16,745 12.2% -
WERVELEND Meerhout €187,065 €23,522 19.8% -
PhysioNext Pelt €311,306 €23,221 14.3% -
OsteoVM Liège €197,663 €14,352 29.5% -

These companies have the same main activity as DEWULF SUZANNE KINESITHERAPIE: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €187,000 and €311,000, founded between 2019 and 2022.

Official details

Source: KBO
Status
Active since 06-01-2020Normal situation
Activity
PhysiotherapyNACE 86951and 2 others
Establishment unit
2.297.584.9568800 Roeselare, since 06-01-2020
Financial year end
30 September
Peppol
Reachable since 13-01-2026
Company details

Annual accounts to 30-09-2025

€235,852▼ 3.9%
Filing
Filed on 27-03-2026, 34 days before the end of the filing period
Financials

Insights on DEWULF SUZANNE KINESITHERAPIE

DEWULF SUZANNE KINESITHERAPIE files the micro format. That format states no turnover. The gross margin fell from €62,573 in 2021 to €17,307 in 2025.

The balance sheet grew most from 2022 to 2024 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DEWULF SUZANNE KINESITHERAPIE

What is the company number of DEWULF SUZANNE KINESITHERAPIE?
The company number of DEWULF SUZANNE KINESITHERAPIE is 0740.748.418. The VAT number is the same number with BE in front: BE 0740.748.418.
Where is DEWULF SUZANNE KINESITHERAPIE based?
The registered office is at Burgemeester Pyckestraat 50, 8500 Kortrijk.Company details
What does DEWULF SUZANNE KINESITHERAPIE do?
According to the KBO register, the main activity is physiotherapy (NACE 86951).
What is the legal form of DEWULF SUZANNE KINESITHERAPIE?
DEWULF SUZANNE KINESITHERAPIE is a private limited company (BV).
When was DEWULF SUZANNE KINESITHERAPIE founded?
DEWULF SUZANNE KINESITHERAPIE was founded on 06-01-2020.
Is DEWULF SUZANNE KINESITHERAPIE still active?
Yes, DEWULF SUZANNE KINESITHERAPIE is an active enterprise in the KBO register.
What is the turnover of DEWULF SUZANNE KINESITHERAPIE?
The turnover in financial year 2025 is ≈ €100,000. This figure is estimated from the gross margin of €17,307 and 44 comparable companies (NACE 869). It probably lies between €69,000 and €200,000. It is a rough estimate.Financials
Is DEWULF SUZANNE KINESITHERAPIE profitable?
In financial year 2025, DEWULF SUZANNE KINESITHERAPIE made a profit of €8,054.
Where can I find the annual accounts of DEWULF SUZANNE KINESITHERAPIE?
DEWULF SUZANNE KINESITHERAPIE filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DEWULF SUZANNE KINESITHERAPIE due?
DEWULF SUZANNE KINESITHERAPIE must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.